ISSN: 8756-3282

Journal Home

Journal Guideline

Bone Q1 Unclaimed

Elsevier Inc. United States

Unfortunately this journal has not been claimed yet. For this reason, some information may be unavailable.

Bone is a journal indexed in SJR in Physiology and Endocrinology, Diabetes and Metabolism with an H index of 224. It has a price of 2385 €. It has an SJR impact factor of 1,179 and it has a best quartile of Q1. It is published in English. It has an SJR impact factor of 1,179.

Bone focuses its scope in these topics and keywords: bone, mass, fractures, gene, mineral, alterations, osteomalacia, therapy, model, osteoporosis, ...

Type: Journal

Type of Copyright:

Languages: English

Open Access Policy: Open Choice

Type of publications:

Publication frecuency: -

Categories: Endocrinology, Diabetes and Metabolism (Q1) Histology (Q1) Physiology (Q1)

Price

2385 €

Inmediate OA

NPD

Embargoed OA

0 €

Non OA

Metrics

1,179

SJR Impact factor

224

H Index

218

Total Docs (Last Year)

1089

Total Docs (3 years)

11706

Total Refs

4280

Total Cites (3 years)

1044

Citable Docs (3 years)

3.59

Cites/Doc (2 years)

53.7

Ref/Doc

Comments

No comments ... Be the first to comment!

Publication speed *

Review quality *

Edition and editorial team *

Institutional email or ORCID *

* The email or ORCID field is only to validate the authenticity of the comment, the identity will not be public. .

Other journals with similar parameters

Circulation Q1
Annual Review of Plant Biology Q1
Nature Metabolism Q1
Annual Review of Physiology Q1
Circulation Research Q1

Compare this journals

Aims and Scope

Best articles by citations

Parathyroid hormone-stimulated resorption in calvaria cultured in serum-free medium is enhanced by the calcium-mobilizing activity of 1,25-Dihydroxyvitamin D3

Histomorphometric and biochemical characterization of bone following acute severe burns in children

Efficacy of intravenous pamidronate in the treatment of patients with osteoporosis

Effects of Bisphosphonates APD and HEBP on Bone Metabolism In Vitro

Epidemiology of fractures in Chile

Prevention of steroid-induced osteoporosis with intermittent intravenous pamidronate : A randomized trial

Cyclical intravenous clodronate in postmenopausal osteoporosis: A 6-year clinical trial

Expression of metalloproteinase-13 (collagenase-3) is induced during fracture healing in mice

Biochemical markers of bone metabolism after short and long time ethanol withdrawal in alcoholics

The changing picture of hip fractures: dramatic change in age distribution and no change in age-adjusted incidence within 10 years in central Finland

Transcriptional regulation of cytochrome P-450 aromatase gene (CYP19) in human osteoblasts in primary cultures

Stochastically simulated assessment of anabolic treatment following varying degrees of cancellous bone resorption

SHOW MORE ARTICLES

Medical management of primary hyperparathyroidism

Could some biomechanical effects of growth hormone help to explain its effects on bone formation and resorption?

Efficiency of strategies to identify postmenopausal women with osteoporosis in Mexico

Muscle-bone interactions, revisited

Changes in parathyroid hormone-related protein and vascular endothelium growth factor in human osteoblasts: relationship with donor age and skeletal site

Aging and accumulation of microdamage in canine bone

A low calcium diet during pregnancy and lactation of rats decreases their bone mineral density, milk production, litter weight, and body calcium

Letters to the editor

New treatments in osteoporosis

Intravenous pamidronate increases bone mineral density and reduces bone remodeling markers in fibrous dysplasia

A new SNP region in the regulatory region of COLIA1 is associated with bone mineral density in perimenopausal Spanish women